While weaker growth is expected in the first half of FY22 as the resurgence in infection softens the favourable base effect, the second half would be supported by better vaccination coverage and stronger global growth, the company said in a report on Monday.
Subscribe to our mailing list to get the latest magazine!
15 hours ago
2 days ago
4 days ago